The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages. 

In this episode, host Dr. Chul Kim moderates a discussion in Korean about highlights from the conference with Dr. Jeongmin Seo and Dr. Jii Bum (Joy) Lee.

Guests:

Dr. Chul Kim, MD
Associate Professor at Georgetown University with a focus on thoracic oncology

Dr. Jeongmin Seo, MD
Clinical Assistant Professor at Seoul National University Bundang Hospital with a focus on thoracic oncology

Dr. Jii Bum (Joy) Lee, MD, PhD
Yonsei Cancer Center, Yonsei University College of Medicine

The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about highlights from the conference with Dr. Jeongmin Seo and Dr. Jii Bum (Joy) Lee. Guests: Dr. Chul Kim, MD Associate Professor at Georgetown University with a focus on thoracic oncology Dr. Jeongmin Seo, MD Clinical Assistant Professor at Seoul National University Bundang Hospital with a focus on thoracic oncology Dr. Jii Bum (Joy) Lee, MD, PhD Yonsei Cancer Center, Yonsei University College of Medicine

LCC in Korean: WCLC 2024 Highlights

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda

Science

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda

Share LCC in Korean: WCLC 2024 Highlights

Sign up to save your podcasts

LCC in Korean: WCLC 2024 Highlights

LCC in Korean: WCLC 2024 Highlights

More shows like Lung Cancer Considered

Lung Cancer Update

Freakonomics Radio

NEJM This Week

Hidden Brain

ASCO Daily News

The Daily

Today, Explained

ASCO Guidelines

OncLive® On Air

Plenary Session

Oncology Today with Dr Neil Love

Conversations in Lung Cancer Research

The Ezra Klein Show

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions